2 of the Worst Stocks in Today's Trading

Needham lowered its price target on WWE stock

Oct 2, 2019 at 2:50 PM
facebook twitter linkedin


The U.S. stock market is spiraling for a second straight day, as fears over a potential global recession swirl. Three individual stocks making notable moves are diagnostic imaging specialist Lantheus Holdings Inc (NASDAQ:LNTH), media giant World Wrestling Entertainment, Inc. (NYSE:WWE), and medical device manufacturer Zynex Inc. (NASDAQ:ZYXI). Here's a quick look at what's moving the shares of LNTH, WWE, and ZYXI.

M&A Buzz Levels Lantheus Stock

Lantheus stock is near the bottom of the Nasdaq, down 21.4% at $18.88, after the company said it would buy Progenics Pharmaceuticals (PGNX) in an all-share deal valued at $519.6 million. Today's bear gap sent LNTH stock slicing through recent support at $21, and puts the shares on track to close below their 320-day moving average for the first time since Feb. 1.

There's room for analysts to downwardly revise their ratings in the wake of today's plunge. Currently, all three covering analysts maintain a "strong buy" rating, and the average 12-month price target of $27 is a stiff 41.8% premium to current trading levels.

WWE Options Traders Eye Short-Term Support

Top-rated Needham analyst Laura Martin cut her price target on World Wrestling Entertainment to $88 from $100, citing to uncertainty around offshore content deals, which adds risk to the brokerage firm's 2020 estimates. In reaction, WWE stock is down 7.8% to trade at $65.57, headed toward its biggest one-day drop since April 25, when the shares tumbled 13.3%.

The equity is now down nearly 35% since its brief trek into triple-digit territory in late April, though the $65 level has emerged as a sturdy floor. Options traders today may be betting on this region to hold as support in the near term, with potential sell-to-open activity detected at the October 65 put.

Zynex Stock Pops as 3Q Orders Surge

Zynex stock is up 11% to trade at $10.82, after the company said third-quarter orders grew 95% year-over-year. The healthcare stock has put in a strong performance in 2019, up 264.3% so far, but today's upside is running out of steam near a trendline connecting lower highs since ZYXI's June 25 15-year peak at $11.75.


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earnings guide for Q3 before it's too late!


  
 
Special Offers from Schaeffer's Trading Partners